Recombinant B subunit-bivalent O1,O139 cholera vaccine (Shanghai united cell biotechnology)

重组B亚单位-双价O1，O139霍乱疫苗（上海联合赛尔生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant B subunit-bivalent O1,O139 cholera vaccine (Shanghai united cell biotechnology)

Drug Alias NameN/A

ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsDiarrheaCholera

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesShanghai United Cell Biotechnology Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A

Inactive CompaniesShanghai United Cell Biotechnology Co Ltd

Active IndicationsN/A

Inactive IndicationsDiarrheaCholera

Other Information

ATC CodeN/A